Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03455725 · ClinicalTrials.gov registry record · NA
CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
A NA study of Refractory Angina and Chronic Myocardial Ischemia, sponsored by BioCardia.
- Active
- Registry status
- NA
- Development phase
- 343
- Enrollment target
- 2
- Study locations
NCT03455725 is a NA study of Refractory Angina and Chronic Myocardial Ischemia that is active but no longer recruiting, run by BioCardia. The registered enrollment target is 343 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03455725, a NA study of Refractory Angina and Chronic Myocardial Ischemia, is active but no longer recruiting, sponsored by BioCardia.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 343 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment Treatment Group: Subjects treated with aBMC using the CardiAMP cell therapy system Sham Control Group: Subjects treated with a Sham Treatment (no introduction of the Helix transendocardial delivery catheter, no administration of aBMC)
Conditions Studied
Interventions
- DEVICE CardiAMP Cell Therapy System
- OTHER Sham Treatment
Study Locations (2)
Florida
- University of Florida - Gainesville
Wisconsin
- University of Wisconsin Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2021-06-30 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03455725
The ClinicalTrials.gov registry entry for NCT03455725 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 343 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioCardia, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Refractory Angina appearing as the primary indexed condition, and to 2 interventions - of which CardiAMP Cell Therapy System is the first listed.
NCT03455725 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03455725 about?
NCT03455725 is a clinical study titled "CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial". Prospective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment Treatment Group: Subjects treated with aBMC using the CardiAMP cell therapy system Sham Control Group: Subject...
What is the current status of trial NCT03455725?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 343 participants. The study started on 2021-06-30. Estimated completion is 2027-12.
What conditions does trial NCT03455725 study?
This clinical trial studies the following conditions: Refractory Angina, Chronic Myocardial Ischemia.
What interventions are being tested in trial NCT03455725?
The interventions under investigation include: CardiAMP Cell Therapy System (DEVICE), Sham Treatment (OTHER).
Who is sponsoring clinical trial NCT03455725?
This trial is sponsored by BioCardia, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03455725 being conducted?
This trial has 2 study locations across Florida, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractory Angina
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.